In addition, the antileukemic efficacy of Na2EA was determined in THP-1 and MV4-11 AML mice five weeks after xenotransplantation by monitoring PB and BM CD33 + or CD45 + cells (Figures S11 and S12, respectively). The gene discussed is CD33; the disease is acute myeloid leukemia.